<?xml version="1.0" encoding="UTF-8"?>
<p id="p0270">The availability of bioinformatics tools and advances made in genetics, immunogenomics, recombinant DNA technology, and others have provided the impetus to design the new age peptide vaccines which have considerable advantages over traditional vaccines:
 <list list-type="simple" id="l0015">
  <list-item id="u0010">
   <label>•</label>
   <p id="p0275">The products can be manufactured as synthetic peptides like any chemicals with stringent purity and quality controls;</p>
  </list-item>
  <list-item id="u0015">
   <label>•</label>
   <p id="p0280">Production of peptides is simple, fast, and cost-effective;</p>
  </list-item>
  <list-item id="u0020">
   <label>•</label>
   <p id="p0285">Problems associated with biological contamination of the antigens are removed;</p>
  </list-item>
  <list-item id="u0025">
   <label>•</label>
   <p id="p0290">The products are typically stable under normal storage conditions;</p>
  </list-item>
  <list-item id="u0030">
   <label>•</label>
   <p id="p0295">The peptides can be primed to avoid allergic or autoimmune responses, ideally, and in principle, can be designed for individual needs.</p>
  </list-item>
 </list>
</p>
